What's in a name? Developing definitions for common health technology assessment product types of the International Network of Agencies for Health Technology Assessment (inahta)
- PMID: 25397872
- DOI: 10.1017/S0266462314000543
What's in a name? Developing definitions for common health technology assessment product types of the International Network of Agencies for Health Technology Assessment (inahta)
Abstract
Objectives: A mapping exercise was undertaken to determine how HTA is being described and conducted across the International Network of Agencies for Health Technology Assessment (INAHTA), with the aim of harmonizing terminologies and approaches.
Methods: Three progressive surveys were undertaken. In 2010, INAHTA agencies were asked to provide details on all of their HTA products. In 2013, additional information was sought on key methodological characteristics of five of the most common HTA product types. Subsequently, final agreement was sought on three proposed product types.
Results: Forty-five HTA agencies responded to at least one of the surveys. In 2010, twenty-one agencies reported publishing over seventy named HTA products. Core domains associated with full HTA reports were reported by a third of agencies but were labeled differently, so products were classified according to product type (n = 17). Agencies producing short, tailored products increased between 2010 and 2013, with the publication of rapid reviews doubling from 33 percent to 66 percent. In 2013, half of the agencies adapted their common HTA products from documents produced by other agencies. A consensus (>70 percent) was achieved on definitions for HTA reports, mini-HTAs, and rapid reviews.
Conclusions: The product label for an HTA is not always indicative of its content. Terminology has, therefore, been agreed to make explicit the trade-off between rigor and timeliness in three common HTA product types. An INAHTA Product Type (IPT) Mark has been created to identify each of these. It is hoped this will further facilitate HTA adaptation between agencies and reduce duplication of effort.
Keywords: Health Policy/standards.
Similar articles
-
Development of the International Network of Agencies for Health Technology Assessment.Int J Technol Assess Health Care. 2009 Jul;25 Suppl 1:24-7. doi: 10.1017/S0266462309090370. Epub 2009 Jun 8. Int J Technol Assess Health Care. 2009. PMID: 19500434 Review.
-
A preliminary survey on the influence of rapid health technology assessments.Int J Technol Assess Health Care. 2009 Jul;25(3):415-8. doi: 10.1017/S0266462309990067. Int J Technol Assess Health Care. 2009. PMID: 19619362
-
Involvement of consumers in health technology assessment activities by Inahta agencies.Int J Technol Assess Health Care. 2013 Jan;29(1):79-83. doi: 10.1017/S026646231200075X. Epub 2012 Dec 10. Int J Technol Assess Health Care. 2013. PMID: 23217279
-
Managing external risks to health technology assessment programs.Int J Technol Assess Health Care. 2006 Fall;22(4):429-35. doi: 10.1017/S0266462306051348. Int J Technol Assess Health Care. 2006. PMID: 16984675
-
Evaluations of public health interventions produced by health technology assessment agencies: A mapping review and analysis by type and evidence content.Health Policy. 2021 Aug;125(8):1054-1064. doi: 10.1016/j.healthpol.2021.05.009. Epub 2021 May 25. Health Policy. 2021. PMID: 34112508 Review.
Cited by
-
Health Technology Assessment of Vaccines in Italy: History and Review of Applications.Vaccines (Basel). 2024 Sep 24;12(10):1090. doi: 10.3390/vaccines12101090. Vaccines (Basel). 2024. PMID: 39460257 Free PMC article.
-
Quality Assessment of Digital Health Apps: Umbrella Review.J Med Internet Res. 2024 Oct 10;26:e58616. doi: 10.2196/58616. J Med Internet Res. 2024. PMID: 39388698 Free PMC article.
-
Maximizing the benefits of using biosimilars in Egypt.J Pharm Policy Pract. 2023 Jun 26;16(1):79. doi: 10.1186/s40545-023-00581-w. J Pharm Policy Pract. 2023. PMID: 37365620 Free PMC article.
-
Health technology assessment for oral health in the past decade: a scoping review.Int J Technol Assess Health Care. 2023 Mar 27;39(1):e18. doi: 10.1017/S0266462322003312. Int J Technol Assess Health Care. 2023. PMID: 36971267 Free PMC article. Review.
-
The Utility of a Rapid Review Evaluation Process to a National HTA Agency.Pharmacoeconomics. 2022 Feb;40(2):203-214. doi: 10.1007/s40273-021-01093-8. Epub 2021 Oct 12. Pharmacoeconomics. 2022. PMID: 34635994 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources